Business
Rob Van Dam Enters Cannabis Wellness with New Hemp-Derived E-Commerce Platform
LOS ANGELES – WWE Hall of Famer Rob Van Dam aka RVD, long known for his open support of Cannabis, has stepped into the wellness side of the industry with a fresh venture. The move combines his personal experience with products aimed at recovery and everyday use, reflecting how athletes and fans increasingly turn to ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right of consumers and patients to purchase regulated products. The central question was whether legal Cannabis could exist at all. Operators, ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. The global Cannabis concentrate market, valued at roughly $1.6 billion in 2025, is projected to reach $9 billion by 2036 ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the country, in carefully labelled jars of flower, in the inboxes of tens of thousands of patients who, until recently, had ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in the unusual position of allowing adult possession and home cultivation while continuing to block a legal adult-use retail market. For ...
Planet 13 Secures Florida Approval for BHO Extraction Lab
LAS VEGAS – Planet 13 Holdings Inc. announced that it has received approval from the Florida Office of Medical Marijuana Use (OMMU) for its butane hash oil (BHO) extraction facility in the state. The approval completes the final major infrastructure investment in Planet 13 Florida's operational buildout and, for the first time, enables the company ...
Apollo Acquires Emerald in $1.5B Deal: What’s Next for MJBizCon?
LOS ANGELES – Apollo Global Management Inc., one of the world's most powerful alternative asset firms, announced that its managed funds have entered into definitive agreements to acquire Emerald Holding, Inc., the owner of MJBizCon and MJBizDaily, in an all-cash transaction valued at roughly $1.5 billion. The deal will take Emerald off the New York ...
Ascend Wellness Shuts Down Lansing Cultivation Facility
LANSING – In a move that reflects ongoing adjustments in Michigan’s Cannabis sector, Ascend Wellness Holdings is shutting down operations at its Lansing cultivation site. The decision comes after a fire late last year and amid broader market pressures that have challenged many operators. Operations set to end by June 26. The company notified state ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching into Latin America, the other deepening a European foothold. Bioxyne's wholly-owned subsidiary Breathe Life Sciences (BLS) has executed an expanded ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with the short-term financial drag of expansion. The company, specializing in organic premium Cannabis products, posted net revenue of $13.7 million ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s Behavioral Health Administration. The bill authorizes up to five research sites to study the safety and effectiveness of ibogaine for ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more important issue is whether state medical Cannabis licenses, medical designations, and documented medical operations will be enough to qualify under ...
Study: Older Americans Are Turning to Cannabis as an Alternative to Pharmaceuticals
NEW YORK - Older Americans are increasingly looking at Cannabis not as a lifestyle product, but as a practical alternative to traditional pharmaceuticals. A new study highlighted by NORML points to a growing trend among adults aged 60 and older: many are turning to Cannabis products because they are dissatisfied with conventional medications, concerned about ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale pricing in California. The vertically-integrated Cannabis company, known for its large-scale greenhouse operations, reported net revenue of $40.5 million, surpassing ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress following a period of restructuring. For the three months ended March 31, revenue totaled $21.1 million, representing a 24.8% decrease ...
MariMed Reports Q1 2026 Financial Results
NORWOOD – MariMed Inc. turned in another quarter of measured progress in a tough Cannabis market. The company, with operations spanning cultivation, production, and retail facilities across multiple states, has reported year-over-year revenue growth and narrower losses, driven by gains in both retail and wholesale channels. Revenue climbed to $39.5 million in Q1 2026, up ...
Grown Rogue Reports Q1 2026 Financial Results
MEDFORD – Grown Rogue International Inc. delivered solid top-line gains in the opening months of 2026, underscoring its push into select markets while managing pressures in more established ones. The company, known for its focus on craft flower and operational discipline, released results that showed revenue climbing notably year over year. Revenue reached $9.2 million ...
Jushi Reports Q1 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. delivered a quarter of steady operational progress while facing ongoing industry pressures. The multi-state operator recorded year-on-year improvements in revenue and profitability metrics, and completed a significant refinancing of its debt. Revenue came in at $66.4 million for the quarter, a 4% increase year-over-year, with gross profit of $29.9 ...
iAnthus Reports Q1 2026 Financial Results
NEW YORK-TORONTO – iAnthus Capital Holdings posted its fiscal first-quarter results for 2026, revealing a company focused on operational tweaks while navigating softer sales in a competitive Cannabis market. The multi-state operator, active across retail and cultivation, reported figures that highlight both pressures and incremental progress. Revenue reached $33.5 million for the three months ended ...
Organigram Reports Q2 Fiscal 2026 Results
TORONTO – Organigram Global Inc. released its financial results, marking a quarter shaped by shifts in consumer preferences and execution issues in key categories. The Canadian producer, known for holding the top market share position domestically, reported declines in several core metrics while pointing to operational fixes and a major international move. Net revenue fell ...
Cannabis 3.0: From Getting High to Getting Clinical
NEW YORK-Cannabis is entering a new phase, and this one is about much more than consumption. For decades, Cannabis was trapped in prohibition and treated mainly as a legal problem. Then came commercialization, when Cannabis became a consumer product defined by branding, potency, strain names, and the promise of a certain experience. Both phases mattered, ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a portfolio of retail, manufacturing, and related assets, continues to pursue a growth strategy centered on consolidation as it integrates newly ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale greenhouse operations, reported gains in revenue and profitability driven largely by exports. Consolidated net sales climbed 27% year-over-year to $50.2 million, with net income attributable to shareholders of $2.9 million. Adjusted EBITDA from continuing operations rose to $9.9 million, representing roughly 20% of sales. The ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two non-intoxicating Cannabis compounds, CBD and CBG, significantly reduced liver fat and improved metabolic health in experimental models of fatty liver ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The deeper opportunity is understanding how Cannabis interacts with one of the body’s most important regulatory networks: the endocannabinoid system. The ...
